Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124484412 | 12448441 | 2 | F | 20140529 | 20160630 | 20160608 | 20160711 | EXP | PHHY2014JP163054 | SANDOZ | 80.25 | YR | M | Y | 50.00000 | KG | 20160711 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124484412 | 12448441 | 1 | SS | EQUA TAB | VILDAGLIPTIN | 1 | Oral | 50 MG, BID (MORNING AND EVENING) | 0 | 50 | MG | BID | |||||||
| 124484412 | 12448441 | 2 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 10 MG, UNK | Y | U | 18569 | 10 | MG | ||||||
| 124484412 | 12448441 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, UNK | Y | U | 18569 | 20 | MG | ||||||
| 124484412 | 12448441 | 4 | SS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 2 MG, UNK | 0 | 2 | MG | TABLET | |||||||
| 124484412 | 12448441 | 5 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 124484412 | 12448441 | 6 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 124484412 | 12448441 | 7 | C | PLETAAL | CILOSTAZOL | 1 | Oral | UNK | Y | 0 | |||||||||
| 124484412 | 12448441 | 8 | C | WARFARIN | WARFARIN | 1 | Oral | UNK | 0 | ||||||||||
| 124484412 | 12448441 | 9 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 124484412 | 12448441 | 10 | C | LUPRAC | TORSEMIDE | 1 | Unknown | 4 MG, UNK | U | 0 | 4 | MG | |||||||
| 124484412 | 12448441 | 11 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124484412 | 12448441 | 1 | Type 2 diabetes mellitus |
| 124484412 | 12448441 | 2 | Hypertension |
| 124484412 | 12448441 | 3 | Cardiac failure |
| 124484412 | 12448441 | 4 | Hypertension |
| 124484412 | 12448441 | 5 | Prophylaxis |
| 124484412 | 12448441 | 6 | Hyperuricaemia |
| 124484412 | 12448441 | 7 | Cerebral infarction |
| 124484412 | 12448441 | 8 | Atrial fibrillation |
| 124484412 | 12448441 | 9 | Hypertension |
| 124484412 | 12448441 | 10 | Cardiac failure |
| 124484412 | 12448441 | 11 | Cerebrovascular accident |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124484412 | 12448441 | HO |
| 124484412 | 12448441 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124484412 | 12448441 | Blister | |
| 124484412 | 12448441 | Blood pressure decreased | |
| 124484412 | 12448441 | Blood urea increased | |
| 124484412 | 12448441 | Cardiac failure | |
| 124484412 | 12448441 | Decreased appetite | |
| 124484412 | 12448441 | Oedema | |
| 124484412 | 12448441 | Pemphigoid | |
| 124484412 | 12448441 | Pruritus | |
| 124484412 | 12448441 | Rash | |
| 124484412 | 12448441 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124484412 | 12448441 | 1 | 20130812 | 0 | ||
| 124484412 | 12448441 | 2 | 20150414 | 0 | ||
| 124484412 | 12448441 | 3 | 20150416 | 20150527 | 0 | |
| 124484412 | 12448441 | 7 | 20150501 | 0 | ||
| 124484412 | 12448441 | 10 | 20150528 | 0 | ||
| 124484412 | 12448441 | 11 | 20150502 | 0 |